Centessa Pharmaceuticals (CNTA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

16.750
+0.400+2.45%

Close Dec 31 16:00 ET

16.750
0.0000.00%

Post 16:00 ET

2.21BMarket Cap-11.02P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Shares Could Be 30% Below Their Intrinsic Value Estimate
Yahoo FinanceJan 1 05:17 ET
Centessa Pharmaceuticals Secures Loan Facility, Repays Debt
MT NewswiresDec 31 13:22 ET
Five Reasons Why UBS Is Overweight the UK
Seeking AlphaDec 20, 2024 13:30 ET
Why Did Centessa Pharmaceuticals PLC (CNTA) Jump Yesterday?
Yahoo FinanceDec 20, 2024 10:31 ET
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
MT NewswiresDec 6, 2024 17:06 ET
Is Centessa Pharmaceuticals (NASDAQ:CNTA) Using Too Much Debt?
Simply Wall StDec 2, 2024 07:25 ET

Comments

Stock_Drift

Sep 26, 2024 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23, 2024 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22, 2024 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy